Trimeris, Inc. Reports Financial Results for the Second Quarter 2008 and Top-Line Results from Its Phase 1 Clinical Study of TRI-1144

DURHAM, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (NASDAQ:TRMS) today announced financial results for the three months ended June 30, 2008, reporting net income of $590,000, or $0.03 per share compared with $4.7 million, or $0.21 per share for the three months ended June 30, 2007. This result was primarily driven by decreased FUZEON® sales and two one-time events recorded during the second quarter of 2008.
MORE ON THIS TOPIC